Cookson Peirce & Co’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33M Sell
155,589
-753
-0.5% -$148K 1.09% 24
2026
Q1
$30.6M Sell
156,342
-5,161
-3% -$1M 1.3% 21
2025
Q4
$28M Sell
161,503
-2,275
-1% -$414K 1.16% 23
2025
Q3
$31.2M Sell
163,778
-6,032
-4% -$1.07M 1.28% 26
2025
Q2
$30.5M Sell
169,810
-2,842
-2% -$494K 1.34% 27
2025
Q1
$29.2M Buy
+172,652
New +$28.4M 1.47% 22
2017
Q4
Sell
-63,675
Closed -$5.96M 155
2017
Q3
$5.96M Sell
63,675
-22,140
-26% -$2.35M 0.62% 53
2017
Q2
$9.54M Sell
85,815
-1,690
-2% -$179K 1.08% 36
2017
Q1
$8.59M Sell
87,505
-1,210
-1% -$115K 1.04% 38
2016
Q4
$8.15M Sell
88,715
-560
-0.6% -$48.3K 1.13% 31
2016
Q3
$7.55M Buy
89,275
+60,395
+209% +$5.07M 1.07% 31
2016
Q2
$2.35M Buy
+28,880
New +$2.2M 0.35% 62

Other funds holding DGX

Cookson Peirce & Co's DGX Position: Q2 2026 in Review

Cookson Peirce & Co reduced its Quest Diagnostics (DGX) stake by 0.48% in Q2 2026, selling an estimated $148K and leaving 155,589 shares worth $33M. The position accounts for 1.09% of the portfolio, ranked #24.

Cookson Peirce & Co first reported a position in DGX in Q2 2016 and has held it in 12 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Cookson Peirce & Co held 155,589 shares of Quest Diagnostics worth $33M as of Q2 2026.
  • Cookson Peirce & Co sold 753 Quest Diagnostics shares in Q2 2026, an estimated $148K.
  • Quest Diagnostics made up 1.09% of Cookson Peirce & Co's portfolio in Q2 2026, its #24 holding.
  • Cookson Peirce & Co first reported a position in Quest Diagnostics in Q2 2016 and has held it in 12 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.